NICHEY

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics | #healthcare

Indlæser..

Holde øje

Holde øje Hjul

Begivenheder

Gennemse begivenheder Mine begivenheder

Blog

Gennemse artikler

Marked

Seneste produkter

sider

Mine sider Synes godt om sider

Mere

Forum Udforske Populære opslag Jobs Tilbud Finansiering
Hjul Holde øje Begivenheder Marked Blog Mine sider Se alt

k kumar
k kumar  oprettet en ny artikel
1 Y

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics | #healthcare

Andet

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics

HR+ HER2- breast cancer is the most common subtype, making up around 70% of all breast cancer cases. Characterized by hormone receptor positivity and the absence of HER2 overexpression, the prevalence of HR+ HER2- breast cancer varies globally.
Synes godt om
Seneste produkter Se alt